ATC code J07

ATC code J07 Vaccines is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1]^[2]^[3] Subgroup J07 is part of the anatomical group J Antiinfectives for systemic use.^[4]

National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.

J07A Bacterial vaccines

J07AC Anthrax vaccines

J07AC01 Anthrax antigen

J07AD Brucellosis vaccines

J07AD01 Brucella antigen

J07AE Cholera vaccines

J07AE01 Cholera, inactivated, whole cell

J07AE02 Cholera, live attenuated

J07AE51 Cholera, combinations with typhoid vaccine, inactivated, whole cell

J07AF Diphtheria vaccines

J07AF01 Diphtheria toxoid

J07AG Haemophilus influenzae B vaccines

J07AG01 Hemophilus influenzae B, purified antigen conjugated

J07AG51 Hemophilus influenzae B, combinations with toxoids

J07AG52 Hemophilus influenzae B, combinations with pertussis and toxoids

J07AG53 Hemophilus influenzae B, combinations with meningococcus C, conjugated

J07AG54 Haemophilus influenza B, combinations with meningococcus C, Y, conjugated

J07AH Meningococcal vaccines

J07AH01 Meningococcus A, purified polysaccharides antigen

J07AH02 Other meningococcal monovalent purified polysaccharides antigen

J07AH03 Meningococcus A, C, bivalent purified polysaccharides antigen

J07AH04 Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen

J07AH05 Other meningococcal polyvalent purified polysaccharides antigen

J07AH06 Meningococcus B, outer membrane vesicle vaccine

J07AH07 Meningococcus C, purified polysaccharides antigen conjugated

J07AH08 Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen conjugated

J07AH09 Meningococcus B, multicomponent vaccine

J07AH10 Meningococcus A, purified polysaccharides antigen conjugated

J07AH11 Meningococcus A,B,C,Y,W-135, pentavalent purified polysaccharides antigen conjugated and factor H binding protein

J07AJ Pertussis vaccines

J07AJ01 Pertussis, inactivated, whole cell

J07AJ02 Pertussis, purified antigen

J07AJ51 Pertussis, inactivated, whole cell, combinations with toxoids

J07AJ52 Pertussis, purified antigen, combinations with toxoids

J07AK Plague vaccines

J07AK01 Plague, inactivated, whole cell

J07AL Pneumococcal vaccines

J07AL01 Pneumococcus, purified polysaccharides antigen

J07AL02 Pneumococcus, purified polysaccharides antigen conjugated

J07AL52 Pneumococcus purified polysaccharides antigen and Haemophilus influenzae, conjugated

J07AM Tetanus vaccines

J07AM01 Tetanus toxoid

J07AM51 Tetanus toxoid, combinations with diphtheria toxoid

J07AM52 Tetanus toxoid, combinations with tetanus immunoglobulin

J07AN Tuberculosis vaccines

J07AN01 Tuberculosis, live attenuated

J07AP Typhoid vaccines

J07AP01 Typhoid, oral, live attenuated

J07AP02 Typhoid, inactivated, whole cell

J07AP03 Typhoid, purified polysaccharide antigen

J07AP10 Typhoid, combinations with paratyphi types

J07AR Typhus (exanthematicus) vaccines

J07AR01 Typhus exanthematicus, inactivated, whole cell

J07AX Other bacterial vaccines

J07AX01 Leptospira vaccines

J07B Viral vaccines

J07BA Encephalitis vaccines

J07BA01 Encephalitis, tick-borne, inactivated, whole virus

J07BA02 Encephalitis, Japanese, inactivated, whole virus

J07BA03 Encephalitis, Japanese, live attenuated

J07BB Influenza vaccines

J07BB01 Influenza inactivated, whole virus

J07BB02 Influenza, purified antigen

J07BB03 Influenza, live attenuated

J07BB04 Influenza, virus like particles

J07BB05 Influenza, RNA-based vaccine

J07BB55 Influenza and covid-19, RNA-based vaccine

J07BC Hepatitis vaccines

J07BC01 Hepatitis B, purified antigen

J07BC02 Hepatitis A, inactivated, whole virus

J07BC20 Combinations

J07BD Measles vaccines

J07BD01 Measles, live attenuated

J07BD51 Measles, combinations with mumps, live attenuated

J07BD52 Measles, combinations with mumps and rubella, live attenuated

J07BD53 Measles, combinations with rubella, live attenuated

J07BD54 Measles, combinations with mumps, rubella and varicella, live attenuated

J07BE Mumps vaccines

J07BE01 Mumps, live attenuated

J07BF Poliomyelitis vaccines

J07BF01 Poliomyelitis oral, monovalent live attenuated

J07BF02 Poliomyelitis oral, trivalent, live attenuated

J07BF03 Poliomyelitis, trivalent, inactivated, whole virus

J07BF04 Poliomyelitis oral, bivalent, live attenuated

J07BJ51 Rubella, combinations with mumps, live attenuated

J07BK Varicella zoster vaccines

J07BK01 Varicella, live attenuated

J07BK02 Zoster, live attenuated

J07BK03 Zoster, purified antigen

J07BL Yellow fever vaccines

J07BL01 Yellow fever, live attenuated

J07BM Papillomavirus vaccines

J07BM01 Papillomavirus (human types 6, 11, 16, 18)

J07BM02 Papillomavirus (human types 16, 18)

J07BM03 Papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)

J07BN Covid-19 vaccines

J07BN01 Covid-19, RNA-based vaccine

J07BN02 Covid-19, viral vector, non-replicating

J07BN03 Covid-19, inactivated virus

J07BN04 Covid-19, protein subunit

J07BN05 Covid-19, virus-like particles

J07BP Chikungunya vaccines

J07BP01 Chikungunya, live attenuated

J07BP02 Chikungunya, virus-like particles

J07BX Other viral vaccines

J07BX01 smallpox and mpox vaccines

J07BX02 Ebola vaccines

J07BX04 Dengue virus vaccines

J07BX05 Respiratory syncytial virus vaccines

J07BX06 Enterovirus 71 vaccines

J07C Bacterial and viral vaccines

J07CA Bacterial and viral vaccines, combined

J07CA01 Diphtheria-poliomyelitis-tetanus

J07CA02 Diphtheria-pertussis-poliomyelitis-tetanus

J07CA03 Diphtheria-rubella-tetanus

J07CA04 Hemophilus influenzae B and poliomyelitis

J07CA05 Diphtheria-hepatitis B-pertussis-tetanus

J07CA06 Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus

J07CA07 Diphtheria-hepatitis B-tetanus

J07CA08 Hemophilus influenzae B and hepatitis B

J07CA09 Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B

J07CA10 Typhoid-hepatitis A

J07CA11 Diphtheria-Hemophilus influenzae B-pertussis-tetanus-hepatitis B

J07CA12 Diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B

J07CA13 Diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C

J07X Other vaccines

J07XA Parasitic vaccines

J07XA01 Malaria vaccines

References

^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
^ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
^ "ATC/DDD Index 2022: code J07". WHO Collaborating Centre for Drug Statistics Methodology.

[1] "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.

[2] "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.

[3] "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.

[4] "ATC/DDD Index 2022: code J07". WHO Collaborating Centre for Drug Statistics Methodology.

[1]

[2]

[3]

[4]

ATC code J: Antiinfectives for systemic use
J01 Antibacterials for systemic use J02 Antimycotics for systemic use J04 Antimycobacterials J05 Antivirals for systemic use
Human only
J06 Immune sera and immunoglobulins J07 Vaccines
ATCvet only
QJ51 Antibacterials for intramammary use QJ54 Antimycobacterials for intramammary use
Other ATC codes
A B C D G H QI J L M N P R S V